<DOC>
	<DOC>NCT01359787</DOC>
	<brief_summary>The purpose of this study is to evaluate the efficacy and safety of three concentrations of a development drug compared to ointment base (vehicle) in subjects with Atopic Dermatitis (AD).</brief_summary>
	<brief_title>Efficacy and Safety of Different Concentrations of Mapracorat Ointment Over 4 Weeks in Atopic Dermatitis (AD)</brief_title>
	<detailed_description />
	<mesh_term>Dermatitis</mesh_term>
	<mesh_term>Dermatitis, Atopic</mesh_term>
	<mesh_term>Eczema</mesh_term>
	<criteria>Signed written informed consent Diagnosis of atopic dermatitis according to Hanifin and Rajka Criteria Willingness of subject to follow all study procedures Willingness to avoid excessive exposure of diseased areas to natural or artificial sunlight Pregnancy and breastfeeding Clinically relevant disease, which could interfere with the study conduct or the evaluation and interpretation of the study results Clinically manifested immunosuppressive disorder or known history of malignant disease History of relevant drug and/or food allergies</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>January 2015</verification_date>
</DOC>